COVID-19 updates: Elizabeth Warren tests positive
The senator says she's experiencing "mild symptoms."
As the COVID-19 pandemic has swept the globe, more than 5.3 million people have died from the disease worldwide, including over 806,000 Americans, according to real-time data compiled by Johns Hopkins University's Center for Systems Science and Engineering.
About 61.4% of the population in the United States is fully vaccinated against COVID-19, according to data from the Centers for Disease Control and Prevention.
Latest headlines:
US cases up 45% in the last month
The U.S. is now reporting nearly 118,000 new cases each day -- up by 45% in the last month, according to federal data.
Daily COVID-19-related hospital admissions have leapt by 46% in the last month.
Maine and New Hampshire are now averaging more new cases than at any other point in the pandemic, according to federal data.
New Hampshire currently holds the nation's highest case rate, followed by Rhode Island, Maine, Michigan, Wisconsin and Minnesota.
-ABC News' Arielle Mitropoulos
South Africa sees new record case high
South Africa, one of the first countries to detect omicron, reported a record high of 26,976 new cases on Wednesday.
Just 26.09% of South Africa's residents are fully vaccinated, according to Africa CDC.
-ABC News' Christine Theodorou
George Washington University cancels events, moves exams online
George Washington University is joining Princeton, Cornell and NYU by canceling all events and moving exams online.
George Washington officials said there's "a significant increase" in cases, and while people are not severely sick, "it is critical that we act to limit the further spread."
-ABC News' Michelle Stoddart
Fenway Park to reopen as booster site
Boston's historic baseball stadium Fenway Park, which transformed into a mass vaccination site last winter, is expected to reopen its doors as a booster shot location in January, Red Sox officials told ABC News.
The Red Sox are working with the city and the governor's office to finalize the plans, Red Sox spokeswoman Zineb Curran said.
-ABC News' Arielle Mitropoulos
Omicron appears to spread faster and vaccine less effective against it, WHO says
The omicron variant appears to have a "growth advantage" over the delta variant, the World Health Organization said in a technical brief released Sunday.
"It is spreading faster than the delta variant in South Africa where delta circulation was low, but also appears to spread more quickly than the delta variant in other countries where the incidence of delta is high, such as in the United Kingdom," the WHO said in the brief, which was dated Friday. "Whether omicron's observed rapid growth rate in countries with high levels of population immunity is related to immune evasion, intrinsic increased transmissibility, or a combination of both remains uncertain. However, given the current available data, it is likely that omicron will outpace the delta variant where community transmission occurs."
Meanwhile, preliminary findings from South Africa suggest omicron may cause less severe illness than delta, and all cases of omicron reported in Europe to date have been mild or asymptomatic. But the WHO said "it remains unclear to what extent omicron may be inherently less virulent" and that "more data are needed to understand the severity profile."
The WHO also noted that "there are limited available data, and no peer-reviewed evidence, on vaccine efficacy or effectiveness to date for omicron." However, preliminary evidence, and the considerably altered antigenic profile of the variant's spike protein, suggests a reduction in vaccine efficacy against infection and transmission associated with omicron.
"There is some preliminary evidence that the incidence of reinfection has increased in South Africa, which may be associated with humoral (antibody-mediated) immune evasion," the WHO said.
The diagnostic accuracy of routinely used polymerase chain reaction (PCR) test and antigen-based rapid diagnostic test (Ag-RDT) assays does not appear to be influenced by omicron. Therapeutic interventions for the management of severe or critical COVID-19 symptoms associated with omicron are also expected to remain effective, according to the WHO.
"However, monoclonal antibodies will need to be tested individually, for their antigen binding and virus neutralization and these studies should be prioritized," the WHO added.
-ABC News' Christine Theodorou